- Home
- FVRR vs ORGO Comparison
FVRR vs ORGO Comparison
Compare FVRR & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FVRR | ORGO |
|---|---|---|
| Founded | 2010 | 1985 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 533.3M | 348.6M |
| IPO Year | 2019 | 2016 |
Fundamental Metrics
Financial Performance| Metric | FVRR | ORGO |
|---|---|---|
| Price | $10.46 | $2.64 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $18.43 | $7.67 |
| AVG Volume (30 Days) | ★ 1.7M | 686.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1600.00 |
| EPS | N/A | ★ 0.15 |
| Revenue | N/A | ★ $564,169,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.83 | $17.84 |
| P/E Ratio | $22.05 | ★ $17.67 |
| Revenue Growth | N/A | ★ 17.04 |
| 52 Week Low | $10.15 | $2.61 |
| 52 Week High | $34.13 | $7.08 |
Technical Indicators
Market Signals| Indicator | FVRR | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 30.79 | 23.16 |
| Support Level | $10.25 | $2.61 |
| Resistance Level | $17.34 | $5.08 |
| Average True Range (ATR) | 0.54 | 0.22 |
| MACD | 0.15 | -0.05 |
| Stochastic Oscillator | 16.14 | 0.66 |
Price Performance
Historical ComparisonAbout FVRR Fiverr International Ltd. no par value
Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Wiring and Translation, and Video and Animation among others.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.